Susquehanna International Group
TRIB

Susquehanna International Group’s Trinity Biotech TRIB Stock Holding History

Susquehanna International Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Buy
+895
New +$16.6K ﹤0.01% 13124
2026
Q1 		– Sell
-475
Closed -$10.5K – 14123
2025
Q4 		$11.3K Buy
+475
New +$14K ﹤0.01% 12044
2025
Q1 		– Sell
-416
Closed -$11K – 13474
2024
Q4 		$11K Buy
+416
New +$16.7K ﹤0.01% 11978
2024
Q2 		– Sell
-452
Closed -$27.8K – 13255
2024
Q1 		$27.8K Buy
+452
New +$31.8K ﹤0.01% 11738
2023
Q2 		– Sell
-98
Closed -$13.8K – 13154
2023
Q1 		$13.8K Buy
+98
New +$15.2K ﹤0.01% 12142
2022
Q4 		– Sell
-77
Closed -$13K – 13689
2022
Q3 		$13K Buy
77
+6
+8% +$1.16K ﹤0.01% 12733
2022
Q2 		$13K Sell
71
-34
-32% -$6.23K ﹤0.01% 12462
2022
Q1 		$17K Sell
105
-47
-31% -$8.12K ﹤0.01% 12670
2021
Q4 		$33K Buy
+152
New +$43.1K ﹤0.01% 12720
2020
Q4 		– Sell
-95
Closed -$47.2K – 11750
2020
Q3 		$29K Sell
95
-22
-19% -$7.64K ﹤0.01% 10337
2020
Q2 		$38K Buy
117
+32
+38% +$7.32K ﹤0.01% 9820
2020
Q1 		$14K Buy
+85
New +$13.4K ﹤0.01% 10004
2017
Q2 		– Sell
-76
Closed -$64.6K – 9854
2017
Q1 		$68K Buy
+76
New +$71.3K ﹤0.01% 8518
2016
Q4 		– Sell
-289
Closed -$572K – 10166
2016
Q3 		$572K Buy
289
+79
+38% +$148K ﹤0.01% 5829
2016
Q2 		$357K Sell
210
-94
-31% -$159K ﹤0.01% 6682
2016
Q1 		$531K Buy
304
+49
+19% +$78K ﹤0.01% 6296
2015
Q4 		$450K Buy
255
+175
+219% +$310K ﹤0.01% 6968
2015
Q3 		$136K Buy
80
+8
+11% +$19.3K ﹤0.01% 8979
2015
Q2 		$196K Sell
72
-115
-61% -$299K ﹤0.01% 9305
2015
Q1 		$541K Buy
187
+2
+1% +$5.54K ﹤0.01% 6951
2014
Q4 		$485K Sell
185
-75
-29% -$194K ﹤0.01% 7266
2014
Q3 		$713K Sell
260
-35
-12% -$114K ﹤0.01% 6566
2014
Q2 		$1.02M Buy
+295
New +$1.05M ﹤0.01% 6013
2014
Q1 		– Sell
-264
Closed -$1.04M – 9446
2013
Q4 		$994K Buy
264
+35
+15% +$126K ﹤0.01% 5520
2013
Q3 		$748K Buy
+229
New +$670K ﹤0.01% 5784

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Susquehanna International Group's TRIB Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Trinity Biotech (TRIB) in Q2 2026: 895 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #13124 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in TRIB as recently as Q4 2025.

Susquehanna International Group first reported a position in TRIB in Q3 2013 and has held it in 25 quarters since. The position peaked at $1.02M in Q2 2014. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • Susquehanna International Group held 895 shares of Trinity Biotech worth $10.4K as of Q2 2026.
  • Trinity Biotech was a new Susquehanna International Group position in Q2 2026.
  • Trinity Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13124 holding.
  • Susquehanna International Group first reported a position in Trinity Biotech in Q3 2013 and has held it in 25 quarters since.
  • Susquehanna International Group's Trinity Biotech position peaked at $1.02M in Q2 2014.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.